Last year David Spiegel's group at Yale (
http://www.spiegelgroup.yale.edu/ ) synthesized glucosepane,
currently thought to be the dominant form of AGE in human tissues,
and chemically very interesting. From a recent interview, he notes
that he'd be happy to hear from DIYbio folk who want to do things
with glucosepane:
https://www.fightaging.org/archives/2016/02/an-interview-with-researcher-david-spiegel-on-the-development-of-glucosepane-cross-link-breakers.php
Justin Loew: Your synthetic chemistry lab made headlines last year
for synthesizing glucosepane. Many listeners are familiar with the
theory that glucosepane is possibly a significant contributer to the
aging process, being an extracellular cross-linking molecule that
stiffens tissues, but most less familiar with the reasons why it is
so difficult to do anything about it. Why has science been so
stymied in regards to this molecule, even though it has been known
for decades.
David Spiegel: Yes, it is a good question. So, it is a very
difficult molecule to make. Well, two issues: first it is very
difficult molecule to make, but also it is actually a difficult
molecule to isolate. So even though it is found in all of us, it is
found in our tissues, our bones, trying to isolate it in a pure form
from the human body is incredibly difficult. Only very small
quantities are obtained, and the compounds isolated are actually
mixtures of very similar stereoisomers, a kind of different versions
of glucosepane that simply can't be separated. So from my
perspective I thought it would be quite valuable to take on this
challenge, and that is really one of the main areas of focus for my
laboratory, which is making very difficult molecules using
techniques in organic chemistry. So in my mind, this is something
that believed in for a long time. For glucosepane, it is a perfect
marriage of interesting chemistry and incredibly interesting
biology. The biology here is hard, and people have had a hard time,
as you said, studying glucosepane, and of course making it has
proven an incredibly difficult challenge because of its complex and
intricate chemical structure. So we've been very interested in
making it, and now we're in the phase of seeing what we can do with
it, particularly with the goal of breaking glucosepane, or
developing agents that can break glucosepane, that we think can
actually reverse the pathology associated with aging.
Justin Loew: Then for the do-it-yourselfers who might be into
synthetic chemistry, or for the other labs who might be listening
in, is the molecule you synthesized patented? Is your university
licensing the process or the molecule?
David Spiegel: Yes, so it is patented. We are in discussions
surrounding licensing the molecule. We are also providing the
molecule to the community for basically the cost it takes for us to
make it. We want to encourage efforts of all kinds to find
glucosepane breakers, so making it commercially available and
developing collaborations with other laboratories are all very high
on our priority list. For the do-it-yourselfers out there who are
interested, feel free to contact me, and we can certainly make an
arrangement where our lab will provide glucosepane for research
purposes.
Reason